These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 29179872)

  • 1. Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systems in African countries through HPV vaccine introduction.
    Dochez C; Burnett RJ; Mbassi SM; Were F; Musyoki A; Trovoada D; Mphahlele MJ
    Papillomavirus Res; 2017 Dec; 4():66-71. PubMed ID: 29179872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learnt during the national introduction of human papillomavirus (HPV) vaccination programmes in 6 African countries: Stakeholders' perspectives.
    Abdullahi LH; Hussey GD; Wiysonge CS; Kagina BM
    S Afr Med J; 2020 May; 110(6):525-531. PubMed ID: 32880566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
    Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
    Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?
    Amponsah-Dacosta E; Blose N; Nkwinika VV; Chepkurui V
    Front Public Health; 2022; 10():799984. PubMed ID: 35174123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and acceptability of delivering adolescent health interventions alongside HPV vaccination in Tanzania.
    Watson-Jones D; Lees S; Mwanga J; Neke N; Changalucha J; Broutet N; Maduhu I; Kapiga S; Chandra-Mouli V; Bloem P; Ross DA
    Health Policy Plan; 2016 Jul; 31(6):691-9. PubMed ID: 26768827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.
    Hutubessy R; Levin A; Wang S; Morgan W; Ally M; John T; Broutet N
    BMC Med; 2012 Nov; 10():136. PubMed ID: 23146319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV vaccine introduction in Rwanda: Impacts on the broader health system.
    Torres-Rueda S; Rulisa S; Burchett HE; Mivumbi NV; Mounier-Jack S
    Sex Reprod Healthc; 2016 Mar; 7():46-51. PubMed ID: 26826045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project - Botswana, 2013.
    Raesima MM; Forhan SE; Voetsch AC; Hewitt S; Hariri S; Wang SA; Pelletier AR; Letebele M; Pheto T; Ramogola-Masire D; El-Halabi S
    MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(40):1147-9. PubMed ID: 26468997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation.
    Mphuru A; Li AJ; Kyesi F; Mwengee W; Mazige F; Nshunju R; Shayo B; Giattas MR; Loharikar A; Lyimo D
    Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A2-A9. PubMed ID: 33962839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent Health Series: HPV infection and vaccination in sub-Saharan Africa: 10 years of research in Tanzanian female adolescents - narrative review.
    Whitworth H; Changalucha J; Baisley K; Watson-Jones D
    Trop Med Int Health; 2021 Nov; 26(11):1345-1355. PubMed ID: 34310816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019.
    Li AJ; Manzi F; Kyesi F; Makame Y; Mwengee W; Fleming M; Mkopi A; Mmbaga S; Lyimo D; Loharikar A
    Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A38-A48. PubMed ID: 34229889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania.
    Quentin W; Terris-Prestholt F; Changalucha J; Soteli S; Edmunds WJ; Hutubessy R; Ross DA; Kapiga S; Hayes R; Watson-Jones D
    BMC Med; 2012 Nov; 10():137. PubMed ID: 23148516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of a human papillomavirus (HPV) vaccination campaign on routine primary health service provision and health workers in Tanzania: a controlled before and after study.
    Gallagher KE; Erio T; Baisley K; Lees S; Watson-Jones D
    BMC Health Serv Res; 2018 Mar; 18(1):173. PubMed ID: 29530042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda.
    Mugisha E; LaMontagne DS; Katahoire AR; Murokora D; Kumakech E; Seruyange R; Tsu VD
    Afr Health Sci; 2015 Mar; 15(1):33-41. PubMed ID: 25834528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learned.
    Casey RM; Adrien N; Badiane O; Diallo A; Loko Roka J; Brennan T; Doshi R; Garon J; Loharikar A
    Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A10-A16. PubMed ID: 34593269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts.
    Sankaranarayanan R; Basu P; Kaur P; Bhaskar R; Singh GB; Denzongpa P; Grover RK; Sebastian P; Saikia T; Oswal K; Kanodia R; Dsouza A; Mehrotra R; Rath GK; Jaggi V; Kashyap S; Kataria I; Hariprasad R; Sasieni P; Bhatla N; Rajaraman P; Trimble EL; Swaminathan S; Purushotham A
    Lancet Oncol; 2019 Nov; 20(11):e637-e644. PubMed ID: 31674322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia.
    Simuyemba MC; Chama-Chiliba CM; Chompolola A; Sinyangwe A; Bchir A; Asiimwe G; Chibwesha C; Masiye F
    BMC Infect Dis; 2024 Apr; 24(1):369. PubMed ID: 38565994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program.
    Paul P; Fabio A
    Vaccine; 2014 Jan; 32(3):320-6. PubMed ID: 24295804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.